Hercules Capital, Inc. Common Stock (NY:HTGC)

16.37 -0.29 (-1.74%)

Official Closing Price Updated: 7:00 PM EDT, Oct 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hercules Capital, Inc. Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

This Ultra-High Dividend Stock Pays You Almost 12% to Own It. It Can Be Yours For Less Than $20 ↗

October 21, 2023

Hercules Capital has a rich history of dividend payments and outperforming the competition.

Via The Motley Fool

Don’t Forget BDCs For Stable, High-Yield Income ↗

October 18, 2023

The Fed’s aggressive interest rate increases have been good for business development companies.

Via Talk Markets

Topics Economy

Hercules Capital Announces Date for Release of Third Quarter 2023 Financial Results and Conference Call

October 12, 2023

From Hercules Capital, Inc.

Via Business Wire

Hercules Capital Receives Reaffirmed Baa3 Investment Grade Credit and Corporate Rating from Moody’s Investors Service

October 04, 2023

From Hercules Capital, Inc.

Via Business Wire

Where Hercules Capital Stands With Analysts ↗

August 30, 2023

Via Benzinga

Why You Need To Be Buying BDCs Right Now ↗

August 26, 2023

Via Talk Markets

Recap: Hercules Capital Q1 Earnings ↗

May 04, 2023

Via Benzinga

Hercules Capital Announces the Appointment of Mr. Nikos Theodosopoulos to Its Board of Directors

September 25, 2023

From Hercules Capital, Inc.

Via Business Wire

Hercules Receives a BBB+ Reaffirmed Investment Grade Corporate Rating from Kroll Bond Rating Agency, Inc.

August 31, 2023

From Hercules Capital, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For August 30, 2023 ↗

August 30, 2023

Via Benzinga

Expert Ratings for Hercules Capital ↗

April 06, 2023

Via Benzinga

The 3 Most Promising Pharma Stocks to Own Now ↗

August 30, 2023

A pillar to economic growth in a defensive area, these promising pharma stocks are set to rise and give investors one bullish ride.

Via InvestorPlace

When A Secondary Stock Offering Is Great News ↗

August 14, 2023

A secondary stock offering comes with a sharp drop in a company’s stock price. Rapid price declines make investors nervous, wondering if the company is facing troubles.

Via Talk Markets

Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 08, 2023

Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser...

Via Benzinga

RingCentral, Alteryx, International Flavors & Fragrances And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

August 08, 2023

U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Hercules Capital, Inc. Prices Upsized Public Offering of Common Stock

August 07, 2023

From Hercules Capital, Inc.

Via Business Wire

Hercules Capital, Inc. Announces Public Offering of Common Stock

August 07, 2023

From Hercules Capital, Inc.

Via Business Wire

COMPASS Pathways Q2 2023: $148.2M Cash Position, Steady Quarter And 'Strong Progress Across The Business' ↗

August 03, 2023

Psychedelics biotech COMPASS Pathways’ (NASDAQ: CMPS) consolidated unaudited financial results for the second quarter 2023, ended June 30 are as follows:

Via Benzinga

Hercules Capital Reports Second Quarter 2023 Financial Results

August 03, 2023

From Hercules Capital, Inc.

Via Business Wire

Hercules Capital Increases Its Total Cash Distribution to $0.48 per Share for the Second Quarter 2023

August 01, 2023

From Hercules Capital, Inc.

Via Business Wire

Hercules Capital Announces Date for Release of Second Quarter 2023 Financial Results and Conference Call

July 10, 2023

From Hercules Capital, Inc.

Via Business Wire

COMPASS Pathways Secures Up To $50M In Term Loan Facility With Hercules Capital ↗

July 05, 2023

Mental health psychedelics biotech company COMPASS Pathways (NASDAQ: CMPS) received funding for its COMP360 Phase 3 program in Treatment-Resist

Via Benzinga

Hercules Capital Stock: This Double-Digit Yielder’s Muscles Are Sagging ↗

June 14, 2023

Hercules hasn’t cut the regular quarterly dividend since 2010. However, the supplemental dividend has been lowered as recently as March of this year.

Via Talk Markets

The Tech Rally Shows You Need to Buy Stocks Others Hate ↗

June 05, 2023

It is hard to believe that 2022 was a bear market for tech stocks, with steep price declines. A look at some numbers for a few stocks investors hated last year.

Via Talk Markets

Hercules Capital: A Specialized, High-Yield BDC That Benefits From Rising Rates ↗

June 02, 2023

I have four Business Development Companies on my list of recommended stocks. The Fed’s interest rate hikes have proven to be a huge benefit for BDCs. With this in mind, Hercules Capital will continue...

Via Talk Markets

Hercules Capital Announces Date of 2023 Annual Meeting of Stockholders

May 11, 2023

From Hercules Capital, Inc.

Via Business Wire

Hercules Capital Reports First Quarter 2023 Financial Results

May 04, 2023

From Hercules Capital, Inc.

Via Business Wire

Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the First Quarter 2023

May 02, 2023

From Hercules Capital, Inc.

Via Business Wire

Hercules Capital Announces Date for Release of First Quarter 2023 Financial Results and Conference Call

April 20, 2023

From Hercules Capital, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2023 ↗

April 06, 2023

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.